September 15, 2016
Hopkinton State Park, Massachusetts

Solid Supports Gals for Cal

Solid was proud to sponsor the 8th Annual Gals For Cal team at the recent Max Performance Title 9 Triathlon at Hopkinton State Park in Massachusetts. 

The Gals for Cal is an all women's triathlon team 'tri-ing to End Duchenne,' by raising money and awareness for the Jett Foundation. The team was originally inspired by its captain Cindy Quitzau's son, Cal, who is now 14 years old with Duchenne muscular dystrophy.

Solid's founder and head of patient advocacy, Annie Ganot, competed with the Gals alongside several mothers with sons with Duchenne muscular dystrophy and nearly 70 of their supportive friends and family.

"It was an honor and privilege to train and compete with this inspiring and supportive group of women. Our sons, the World's Strongest Boys, motivate and challenge us to do great things, to step (or make giant leaps!) outside of our comfort zones, to make a positive impact, and to play a meaningful part in solving Duchenne." 

- Annie Ganot

This year's team raised more than $80,000 to support local families with adaptive equipment and the Livin' Large Fund, a small grant program of the Jett Foundation that helps Duchenne muscular dystrophy families in Massachusetts and New Hampshire to participate in accessible recreation and social opportunities that may otherwise not be affordable. 

The World’s Strongest Boys

Related news


We’re pleased to share with you that the FDA has lifted the clinical hold on IGNITE DMD.


Letter to the Duchenne Community: Update on IGNITE DMD Clinical Trial


Today we announced that the U.S. Food and Drug Administration has placed our Phase I/II clinical trial for SGT-001, IGNITE DMD, on Clinical Hold following a serious adverse event that occurred in the first patient dosed, a non-ambulatory adolescent.


Solid Biosciences is proud to join the global rare disease community again this year to observe Rare Disease Day


Today we are excited to announce the initiation of our first clinical trial for SGT-001.


We are getting ready to initiate a clinical study for our gene transfer candidate, SGT-001, later this year.


Solid Biosciences is pleased to announce additional research grant from our Australia-based partner Save Our Sons and an initial research grant from Ireland-based Join Our Boys.


The Duchenne Research Fund (DRF) provided Solid with a research grant of $600,000 to support its LTBP4 program to combat fibrosis and to support novel biomarker work in Duchenne muscular dystrophy (DMD).


It has been an exciting and emotional time for our Duchenne muscular dystrophy (DMD) community.


Solid Biosciences joined the Jett Foundation and other members of the local Cambridge, MA community to observe World Duchenne Awareness Day.


More information about Solid?

Please subscribe to receive our latest news